Bank of New York Mellon
ACOR

Bank of New York Mellon’s Acorda Therapeutics, Inc. ACOR Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-25,200
Closed -$17K 4374
2020
Q4
$17K Hold
25,200
﹤0.01% 4195
2020
Q3
$13K Hold
25,200
﹤0.01% 4097
2020
Q2
$19K Sell
25,200
-504,071
-95% -$380K ﹤0.01% 4055
2020
Q1
$494K Sell
529,271
-12,036
-2% -$11.2K ﹤0.01% 3374
2019
Q4
$1.1M Buy
541,307
+59,002
+12% +$120K ﹤0.01% 3191
2019
Q3
$1.38M Buy
482,305
+135
+0% +$387 ﹤0.01% 2961
2019
Q2
$3.7M Sell
482,170
-315,762
-40% -$2.42M ﹤0.01% 2484
2019
Q1
$10.6M Buy
797,932
+315,586
+65% +$4.19M ﹤0.01% 1941
2018
Q4
$7.52M Sell
482,346
-17,465
-3% -$272K ﹤0.01% 2069
2018
Q3
$9.82M Sell
499,811
-28,632
-5% -$563K ﹤0.01% 2035
2018
Q2
$15.2M Sell
528,443
-14,370
-3% -$412K ﹤0.01% 1772
2018
Q1
$12.8M Sell
542,813
-27,457
-5% -$649K ﹤0.01% 1858
2017
Q4
$12.2M Buy
570,270
+14,031
+3% +$301K ﹤0.01% 1893
2017
Q3
$13.2M Buy
556,239
+12,480
+2% +$295K ﹤0.01% 1840
2017
Q2
$10.7M Sell
543,759
-38,539
-7% -$759K ﹤0.01% 1926
2017
Q1
$12.2M Buy
582,298
+32,978
+6% +$693K ﹤0.01% 1847
2016
Q4
$10.3M Buy
549,320
+25,042
+5% +$471K ﹤0.01% 1941
2016
Q3
$10.9M Sell
524,278
-1,414
-0.3% -$29.5K ﹤0.01% 1834
2016
Q2
$13.4M Sell
525,692
-19,158
-4% -$489K ﹤0.01% 1675
2016
Q1
$14.4M Sell
544,850
-155,236
-22% -$4.11M ﹤0.01% 1612
2015
Q4
$30M Sell
700,086
-1,157
-0.2% -$49.5K 0.01% 1123
2015
Q3
$18.6M Buy
701,243
+43,660
+7% +$1.16M 0.01% 1459
2015
Q2
$21.9M Buy
657,583
+23,642
+4% +$788K 0.01% 1423
2015
Q1
$21.1M Buy
633,941
+217,708
+52% +$7.25M 0.01% 1454
2014
Q4
$17M Sell
416,233
-57,627
-12% -$2.36M ﹤0.01% 1586
2014
Q3
$16.1M Sell
473,860
-11,030
-2% -$374K ﹤0.01% 1598
2014
Q2
$16.3M Sell
484,890
-24,554
-5% -$828K ﹤0.01% 1620
2014
Q1
$19.3M Buy
509,444
+5,245
+1% +$199K 0.01% 1482
2013
Q4
$14.7M Buy
504,199
+61,519
+14% +$1.8M ﹤0.01% 1655
2013
Q3
$15.1M Buy
442,680
+29,794
+7% +$1.02M ﹤0.01% 1578
2013
Q2
$13.6M Buy
+412,886
New +$13.6M ﹤0.01% 1612